18 March 2026
18 March 2026
Health secretary Wes Streeting is considering expanding the existing schedule to age groups beyond infants, such as teenagers.
At Advanced Therapies, investors noted that early planning, adaptability and building trust will help a biotech startup succeed.
During the review process, the FDA provided label drafts in December 2025 and March 2026.
Sanofi’s agent uses mRNA that produces transient CAR-T cells, allowing repeated dosing.
R1 plans to initiate a Phase IIb study of AP306 later this year.
The court ruling reverses several changes by the CDC’s vaccine panel to childhood immunisation recommendations.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
